Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 19.69 0.75 (3.96%) Market Cap: 1.68 Bil Enterprise Value: 1.18 Bil PE Ratio: 0 PB Ratio: 3.85 GF Score: 41/100

Q4 2018 Syndax Pharmaceuticals Inc Earnings Call Transcript

Mar 07, 2019 / 09:30PM GMT
Release Date Price: $6.27 (+0.64%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. We welcome you to Syndax Fourth Quarter and End of Year 2018 Earnings Call. (Operator Instructions) As a reminder, this conference call may be recorded. I would now like to turn the conference over to Melissa Forst with Argot Partners. Please go ahead.

Melissa Forst
Argot Partners, LLC - VP

Thank you. Welcome, and thank you to those of you joining us today for Syndax's Fourth Quarter and 2018 Full Year Financial and Operating Results Conference Call. Joining us this afternoon for prepared remarks will be Dr. Briggs Morrison, Chief Executive Officer; and Rick Shea, Chief Financial Officer.

Also joining us on the call today for the question-and-answer session are Michael Metzger, President and Chief Operating Officer; Dr. Michael Meyers, Chief Medical Officer; and Dr. Peter Ordentlich, Chief Scientific Officer.

This call is being accompanied by a slide deck that has been posted on the company's website, so I'll ask you to turn to the forward-looking statements on Slide 2.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot